The Gabrail Pharmacology Phase 1 Research Center
The Gabrail Pharmacology Phase 1 Research Center
Canton, Ohio, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| XTX301 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-06-23 | NCT05684965 |